Medication topics
Sulfasalazine articles covering 5-ASA treatment, safety, access, and ulcerative colitis or broader IBD care decisions. Medication context emphasizes treatment decisions, safety, approvals, and therapy access.
2 articles
Market reports can signal which drugs, companies, and biosimilars are becoming more available and may affect access and cost. Announcements about biosimilars could influence treatment affordability and prescribing...
You can have active intestinal inflammation even without clear symptoms; early monitoring and tailored treatment aim to prevent complications and preserve quality of life.
